SCHEMBL9503298

SCHEMBL9503298

[c]1cc[c]c2c1-c1ccccc1-2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CDC25B P30305 2/20 0.35
ALDH1A1 P00352 4/20 0.33
NPC1 O15118 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPK1 P28482 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
MAOA P21397 2/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
RECQL P46063 2/20 0.33
RAB9A P51151 2/20 0.33
BLM P54132 2/20 0.33
CES2 O00748 1/20 0.33
APAF1 O14727 1/20 0.33
TERT O14746 1/20 0.33
PLIN1 O60240 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8493 0.79 MEN1 (0.35) MEN1KMT2ACDC25BALDH1A1NPC1
SCHEMBL4819516 0.79 MEN1 (0.35) MEN1KMT2ACDC25BALDH1A1NPC1
SCHEMBL195383 0.79 MEN1 (0.35) MEN1KMT2ACDC25BALDH1A1NPC1
SCHEMBL646330 0.77 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2MAPK1L3MBTL1KDM4E
SCHEMBL56824 0.77 CDC25B (0.55) MEN1KMT2ACDC25BALDH1A1NPC1
SCHEMBL2407852 0.75 ALDH1A1 (0.52) MEN1KMT2AALDH1A1MAPK1L3MBTL1
SCHEMBL2407346 0.75 ALDH1A1 (0.40) ALDH1A1MAPK1L3MBTL1KDM4ECES2
SCHEMBL15062683 0.73
SCHEMBL15062516 0.73
SCHEMBL10337930 0.72 ALDH1A1 (0.57) MEN1KMT2AALDH1A1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0364892-B1 WHOLLY AROMATIC POLYAMIDES, PROCESS FOR PRODUCING THE SAME AND SHAPED ARTICLES HOECHST AKTIENGESELLSCHAFT (DE) 1993-06-09 EP claimed
EP-0364891-B1 WHOLLY AROMATIC POLYAMIDES, PROCESS FOR PRODUCING THE SAME AND SHAPED ARTICLES HOECHST AKTIENGESELLSCHAFT (DE) 1993-06-09 EP claimed
US-10472381-B2 Sialic acid derivatives REINHARD BROSSMER (DE) 2019-11-12 US disclosed
WO-2018172129-A1 SIALIC ACID DERIVATIVES WITH C-C TRIPLE BOND, AND PREPARATION THEREOF PRESCHER HORST (CH) 2018-09-27 WO disclosed
EP-3129390-A1 SIALIC ACID DERIVATIVES Brossmer, Reinhard (DE) 2017-02-15 EP disclosed
US-20160362436-A1 SIALIC ACID DERIVATIVES BROSSMER REINHARD (DE) 2016-12-15 US disclosed
EP-2797946-B1 SIALIC ACID DIMERS BROSSMER REINHARD (DE) 2016-05-04 EP disclosed
US-9260467-B2 Sialic acid dimers BROSSMER REINHARD (DE) 2016-02-16 US disclosed
WO-2015128344-A1 SIALIC ACID DERIVATIVES BROSSMER REINHARD (DE) 2015-09-03 WO disclosed
EP-2910561-A1 Sialic acid derivatives Brossmer, Reinhard (DE) 2015-08-26 EP disclosed
US-20150005245-A1 Sialic Acid Dimers BROSSMER REINHARD (DE) 2015-01-01 US disclosed
EP-2797946-A1 SIALIC ACID DIMERS Brossmer, Reinhard (DE) 2014-11-05 EP disclosed
WO-2013097942-A1 SIALIC ACID DIMERS BROSSMER REINHARD (DE) 2013-07-04 WO disclosed
EP-2610263-A1 Sialic acid dimers Brossmer, Reinhard (DE) 2013-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10472381-B2 Sialic acid derivatives NEU1, NEU2, NEU3 MEN1 1137/4885KMT2A 4412/4885CDC25B 3997/4885
US-20160362436-A1 SIALIC ACID DERIVATIVES NEU1, NEU2, NEU3 MEN1 1135/4885KMT2A 4414/4885CDC25B 3994/4885
US-20150005245-A1 Sialic Acid Dimers SIGLEC9, SIGLEC7, NEU2 MEN1 2389/4885KMT2A 3967/4885CDC25B 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.